Toby Ferguson

CIK 2015616 · View on SEC EDGAR ↗

Insider

First SEC filing: Feb. 10, 2026 · Latest: Feb. 10, 2026

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 6 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

6 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
Aug. 18, 2025 VYGR S 19,000 $3.73 $70,870 138,914 Direct -12.03% Disposed -8.7% (price as of 2026-08-19)
April 2, 2025 VYGR S 10,086 $3.43 $34,595 157,914 Direct -6.00% Disposed -0.7% (price as of 2026-08-19)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
Feb. 6, 2026 VYGR Stock Option (Right to Buy) Common Stock (210,000) $3.68 Feb. 6, 2036 210,000 Acquired
Feb. 21, 2025 VYGR Stock Option (Right to Buy) Common Stock (126,000) $4.22 Feb. 21, 2035 126,000 Acquired
March 25, 2024 VYGR Stock Option (Right to Buy) Common Stock (210,000) $9.26 March 25, 2034 210,000 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

VYGR

M.D., Ph.D. Former Chief Medical Officer
Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2024 $363,750 — $1,106,700 $1,333,500 $148,159 — $14,688 $2,966,797

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.